S100A6 and neoplasm: The finding of S100A6 loss of expression in a significant proportion of high-grade PIN lesions as well as in all cases of adenocarcinoma, regardless of Gleason score and in metastatic lesions, suggests that loss of expression occurs at an early stage of prostate tumour development and that loss of expression is maintained throughout tumour progression.